{"entity":{"type":"insider","cik":"0001619052","url":"/insider/0001619052","json_url":"/insider/0001619052.json","name":"Ho Peter Tai-Ching","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":15,"first":"2014-12-04","last":"2017-10-25","span_basis":"filed_date"},"name_variants":[{"name":"Ho Peter Tai-Ching","source":"filing","n_filings":15,"first_seen":"2014-12-04","last_seen":"2017-10-25"}],"transactions":[{"id":4785516,"accession":"0001209191-17-057916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057916","line_url":"/filing/0001209191-17-057916#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.4394,"price_display":"16.44","price_state":"stated","total_value":246591.0,"total_display":"246,591.00","total_whole":"246,591","shares_owned_after":8123.0,"shares_owned_after_display":"8,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-24","filed_date":"2017-10-25","scope":"insider"},{"id":4661053,"accession":"0001209191-17-053994","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-053994","line_url":"/filing/0001209191-17-053994#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.8051,"price_display":"16.81","price_state":"stated","total_value":252076.5,"total_display":"252,076.50","total_whole":"252,077","shares_owned_after":8123.0,"shares_owned_after_display":"8,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-26","scope":"insider"},{"id":4832697,"accession":"0001209191-17-050363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-050363","line_url":"/filing/0001209191-17-050363#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.6844,"price_display":"15.68","price_state":"stated","total_value":235266.0,"total_display":"235,266.00","total_whole":"235,266","shares_owned_after":7228.0,"shares_owned_after_display":"7,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-24","filed_date":"2017-08-28","scope":"insider"},{"id":4944267,"accession":"0001209191-17-046346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-046346","line_url":"/filing/0001209191-17-046346#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":13.4381,"price_display":"13.44","price_state":"stated","total_value":201571.5,"total_display":"201,571.50","total_whole":"201,572","shares_owned_after":7228.0,"shares_owned_after_display":"7,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-24","filed_date":"2017-07-26","scope":"insider"},{"id":4709913,"accession":"0001209191-17-041943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-041943","line_url":"/filing/0001209191-17-041943#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":14.8743,"price_display":"14.87","price_state":"stated","total_value":223114.5,"total_display":"223,114.50","total_whole":"223,115","shares_owned_after":7228.0,"shares_owned_after_display":"7,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-27","scope":"insider"},{"id":4162119,"accession":"0001209191-17-035709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-035709","line_url":"/filing/0001209191-17-035709#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.1109,"price_display":"16.11","price_state":"stated","total_value":241663.5,"total_display":"241,663.50","total_whole":"241,664","shares_owned_after":7228.0,"shares_owned_after_display":"7,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-25","filed_date":"2017-05-26","scope":"insider"},{"id":3140059,"accession":"0001209191-16-154664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-154664","line_url":"/filing/0001209191-16-154664#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.8941,"price_display":"10.89","price_state":"stated","total_value":2178.82,"total_display":"2,178.82","total_whole":"2,179","shares_owned_after":5520.0,"shares_owned_after_display":"5,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-08","filed_date":"2016-12-12","scope":"insider"},{"id":3290173,"accession":"0001209191-16-104612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-104612","line_url":"/filing/0001209191-16-104612#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":636.0,"shares_display":"636","price_per_share":7.4715,"price_display":"7.47","price_state":"stated","total_value":4751.874,"total_display":"4,751.87","total_whole":"4,752","shares_owned_after":5358.0,"shares_owned_after_display":"5,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-02","scope":"insider"},{"id":8677397,"accession":"0001209191-15-084514","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-084514","line_url":"/filing/0001209191-15-084514#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":14.69,"price_display":"14.69","price_state":"stated","total_value":14690.0,"total_display":"14,690.00","total_whole":"14,690","shares_owned_after":4722.0,"shares_owned_after_display":"4,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-10","scope":"insider"},{"id":8094680,"accession":"0001209191-15-069015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-069015","line_url":"/filing/0001209191-15-069015#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":522.0,"shares_display":"522","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":8874.0,"total_display":"8,874.00","total_whole":"8,874","shares_owned_after":3522.0,"shares_owned_after_display":"3,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-31","filed_date":"2015-09-02","scope":"insider"},{"id":9269955,"accession":"0001209191-16-111226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-111226","line_url":"/filing/0001209191-16-111226#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":16.51,"price_display":"16.51","price_state":"stated","total_value":33020.0,"total_display":"33,020.00","total_whole":"33,020","shares_owned_after":2200.0,"shares_owned_after_display":"2,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2016-03-31","scope":"insider"},{"id":8774797,"accession":"0001209191-15-067592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-067592","line_url":"/filing/0001209191-15-067592#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":16.51,"price_display":"16.51","price_state":"stated","total_value":33020.0,"total_display":"33,020.00","total_whole":"33,020","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-24","scope":"insider"},{"id":8460174,"accession":"0001209191-15-039539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-039539","line_url":"/filing/0001209191-15-039539","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":16.3555,"price_display":"16.36","price_state":"stated","total_value":13084.4,"total_display":"13,084.40","total_whole":"13,084","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-05","filed_date":"2015-05-06","scope":"insider","n_lines":2},{"id":6594350,"accession":"0001209191-14-076786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-076786","line_url":"/filing/0001209191-14-076786","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":17.63,"price_display":"17.63","price_state":"stated","total_value":7052.0,"total_display":"7,052.00","total_whole":"7,052","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-18","scope":"insider","n_lines":2},{"id":6323392,"accession":"0001209191-14-073199","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-073199","line_url":"/filing/0001209191-14-073199","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001619052","owner_name":"Ho Peter Tai-Ching","owner_display_name":"Ho Peter Tai-Ching","owner_url":"/insider/0001619052","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":21.168,"price_display":"21.17","price_state":"stated","total_value":21168.0,"total_display":"21,168.00","total_whole":"21,168","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-04","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer (Chief Development Officer)","n_filings":15,"first_seen":"2014-12-04","last_seen":"2017-10-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001619052","retrieved_at":"2026-08-24T18:01:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}